MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells

MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways

(2016) Yanmin Xu et al.   CANCER LETTERS

Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1

(2016) Rui Ge et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

VHL-deficient renal cancer cells gain resistance to mitochondria-activating apoptosis inducers by activating AKT through the IGF1R-PI3K pathway

(2016) Ryuji Yamaguchi et al.   TUMOR BIOLOGY

Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor

(2016) Batzaya Davaadelger et al.   Oncotarget

SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma

(2016) Christoph Willmes et al.   Oncotarget

Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1

(2016) Lei Shi et al.   FEBS Open Bio

MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1

(2015) Yuanmin Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma

(2015) J.-J. Zhao et al.   CANCER RESEARCH

The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma

(2015) Xue-jun Shao et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2

(2014) Mifang Yang et al.   Anti-Cancer Agents in Medicinal Chemistry

Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells

(2014) XIAOJUN GE et al.   ONCOLOGY REPORTS

Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2

(2014) Ming Zhuang et al.   TUMOR BIOLOGY

MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN

(2013) Yan Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN

(2013) Fang Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin

(2013) Y. Zhang et al.   BIOCHEMICAL PHARMACOLOGY

MicroRNA: Function, Detection, and Bioanalysis

(2013) Haifeng Dong et al.   CHEMICAL REVIEWS

miR-135a/b Modulate Cisplatin Resistance of Human Lung Cancer Cell Line by Targeting MCL1

(2013) Li Zhou et al.   PATHOLOGY & ONCOLOGY RESEARCH

microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin

(2013) ZHONGXIAN WANG et al.   Oncology Letters

Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer

(2013) Nir Peled et al.   CELLULAR ONCOLOGY

Gefitinib resistance in HCC mahlavu cells: Upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation

(2011) Adam S. Bodzin et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Emerging complexity of microRNA generation cascades

(2010) H. I. Suzuki et al.   JOURNAL OF BIOCHEMISTRY

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells

(2009) Takeshi Haraguchi et al.   NUCLEIC ACIDS RESEARCH